High-throughput drug sensitivity and resistance testing of ovarian cancer cell lines provides useful strategy for assessing drug repositioning and therapeutic possibilities of emerging drugs

Forskningsoutput: TidskriftsbidragMötesabstraktPeer review

Originalspråkengelska
TidskriftClinical Cancer Research
Volym21
Antal sidor1
ISSN1078-0432
DOI
StatusPublicerad - 15 aug 2015
MoE-publikationstypEj behörig
Evenemang10th Biennial Ovarian Cancer Research Symposium - Seattle
Varaktighet: 8 sep 20149 sep 2014

Citera det här